Technologies
Qualigen Therapeutics Inc (QLGN) Has Great Growth Outlook For 2025
Qualigen Therapeutics Inc (NASDAQ:QLGN) has a beta value of -0.16 and has seen 40.81 million shares traded in the recent trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.